Only the expression profiles of CTA genes from the known TAA (NY-ESO-1 and MAGE-A12) and BIRC5, but not ERBB2, displayed elevated cancer expression with low healthy tissue expression (Supplementary Fig. S7c). This evidence concerns the gene CTAG1A and cancer.